Ferroptosis-related genes, GPX4 and FTH1, were reported upregulated in patients undergoing neoadjuvant chemoradiotherapy and associated with recurrence and poor prognosis in CRC, while CRC cells were sensitive to GPX4 inhibitor [46]. This evidence concerns the gene FTH1 and colorectal carcinoma.